HomepageMedicinePharma Pulse 7/5/24: The Impact of FDA's Diversity Action Plan, Apple Poised to Get OpenAI Board Observer Role & more Medicine Pharma Pulse 7/5/24: The Impact of FDA's Diversity Action Plan, Apple Poised to Get OpenAI Board Observer Role & more admin Posted on July 6, 2024 The latest news for pharma industry insiders. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostTruly Free Cleaning Products Review 2024: A Detailed Look Next PostMark Zuckerberg’s Viral Surf Video You Might Also Like Medicine FDA Approves Axsome Therapeutics’ Symbravo for Migraine with or without Aura admin February 1, 2025 Medicine Pharma Pulse 7/4/24: Colder Temperatures May Worsen Asthma Symptoms, New FDA Approved ALZ Drug to Accelerate New Era of Treatment & more admin July 5, 2024 Medicine Pharma Pulse 11/28/24: Nov. 27 Passed—What Does That Mean for DSCSA? & more admin November 28, 2024 Medicine FDA Grants Accelerated Approval to Adaptimmune Therapeutics’ Tecelra for Adults with Synovial Sarcoma Who Have Undergone Prior Chemotherapy admin August 3, 2024
Medicine FDA Approves Axsome Therapeutics’ Symbravo for Migraine with or without Aura admin February 1, 2025
Medicine Pharma Pulse 7/4/24: Colder Temperatures May Worsen Asthma Symptoms, New FDA Approved ALZ Drug to Accelerate New Era of Treatment & more admin July 5, 2024
Medicine Pharma Pulse 11/28/24: Nov. 27 Passed—What Does That Mean for DSCSA? & more admin November 28, 2024
Medicine FDA Grants Accelerated Approval to Adaptimmune Therapeutics’ Tecelra for Adults with Synovial Sarcoma Who Have Undergone Prior Chemotherapy admin August 3, 2024